-
Biogen Inc. (BIIB $139.31)
-
Pfizer Inc. (PFE $25.88)
-
Knight Therapeutics Inc. (GUD $6.45)
-
Theratechnologies Inc. (TH $4.49)
Q: With the patent protection now extended for drugs for two years longer, do you have any suggestions as to co's in that space that might benefit?